Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
About this study
The primary purpose of this protocol is to create a registry of older (≥50 years old) patients with Hematologic Malignancies. Our main objectives include: To understand the prevalence of frailty and geriatric impairments among patients aged ≥50y and above diagnosed with a hematologic malignancy at UAB and to gather information that would lend support for future research in this vulnerable population.
- Condition
- Multiple Myeloma, Amyloidosis, Plasma Cell Leukemia
- Sponsor
- University of Alabama at Birmingham
Who can join
- Age
- 50 years and older
- Sex
- All sexes
- Healthy volunteers
- Not stated
Inclusion 5
- Minimum age: 50 years
- Study condition: Multiple Myeloma, Amyloidosis, Plasma Cell Leukemia
- Patients are ≥50 years of age.
- Patients have a biopsy proven diagnosis of Hematologic Malignancy (Multiple Myeloma, AL Amyloidosis, Waldenstrom's Macrogloblunemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Myelodysplastic syndromes, Myeloproliferative Neoplasm, Acute/Chronic Myeloid Leukemia, Acute/Chronic Lymphoid Leukemia).
- Patients have appointments at UAB including if they are an inpatient or other clinic locations.
Exclusion 2
- Individuals who are \<50 years old.
- Patients who do not read and/or speak English will not be eligible for this study as many of the questionnaires are not validated in other languages. No exclusions will be made based on gender, ethnicity or race.
Where
1 site, 1 recruiting
Kirklin Clinic of UAB Hospital
Birmingham, Alabama, United States
Contact
-
Landon Martin, BS
(205) 638-2120 landoncmartin@uabmc.edu
Potential match only. Final eligibility is determined by the study team.